Efficacy of bortezomib in a direct xenograft model of primary effusion lymphoma.

Sarosiek, Kristopher A

Efficacy of bortezomib in a direct xenograft model of primary effusion lymphoma. [electronic resource] - Proceedings of the National Academy of Sciences of the United States of America Jul 2010 - 13069-74 p. digital

Publication Type: Case Reports; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

1091-6490

10.1073/pnas.1002985107 doi


Aged, 80 and over
Animals
Apoptosis--drug effects
Boronic Acids--pharmacology
Bortezomib
Cell Cycle--drug effects
Chlorocebus aethiops
DNA Replication--drug effects
Down-Regulation--drug effects
E2F3 Transcription Factor--metabolism
Fatal Outcome
Gene Expression Regulation, Neoplastic--drug effects
Herpesvirus 8, Human--drug effects
Humans
Lymphoma, Primary Effusion--drug therapy
Male
Mice
NF-kappa B--metabolism
Proto-Oncogene Proteins c-myc--metabolism
Pyrazines--pharmacology
Survival Analysis
Treatment Outcome
Unfolded Protein Response--drug effects
Vero Cells
Virion--drug effects
Xenograft Model Antitumor Assays